CD19-specific CAR-T cell therapy for relapsed/refractory non-B-cell acute leukaemia with CD19 antigen expression

Eur J Cancer. 2021 Aug:153:1-4. doi: 10.1016/j.ejca.2021.04.042. Epub 2021 Jun 11.

Authors

Shuangyou Liu¹, Zhichao Yin², Xinjian Yu³, Yongqiang Zhao⁴, Jing Pan², Yanzhi Song⁴

Affiliations

¹ Department of Hematology, Beijing Boren Hospital, Beijing, China. Electronic address: liusy@borenhospital.com.
² Department of Hematology, Beijing Boren Hospital, Beijing, China.
³ Medical Laboratory, Beijing Boren Hospital, Beijing, China.
⁴ Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China.

PMID: 34126332
DOI: 10.1016/j.ejca.2021.04.042

No abstract available

Publication types

Letter

MeSH terms

Adult
Antigens, CD19 / metabolism*
Child, Preschool
Female
Humans
Immunotherapy, Adoptive / methods*
Leukemia, Myeloid, Acute / genetics*
Male
Young Adult

Substances

Antigens, CD19